SEP
IRWD icon

Sound Energy Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History

Sound Energy Partners’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-179,100
Closed -$2.3M – 42
2014
Q2 		$2.3M Buy
+179,100
New +$1.95M 2.21% 19

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sound Energy Partners's IRWD Position: Q1 2015 in Review

Sound Energy Partners sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2015, closing a stake of 23,880 shares — an estimated $306K sold.

Sound Energy Partners first reported a position in IRWD in Q2 2013 and held it in 7 quarters. The position peaked at $6.46M in Q2 2014. 142 funds tracked by Wall St. Rank hold IRWD as of Q1 2015.

  • Sound Energy Partners reported no remaining Ironwood Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Sound Energy Partners sold 23,880 Ironwood Pharmaceuticals shares in Q1 2015, an estimated $306K.
  • Sound Energy Partners first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 7 quarters.
  • Sound Energy Partners's Ironwood Pharmaceuticals position peaked at $6.46M in Q2 2014.
  • 142 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2015.

Based on Sound Energy Partners's 13F filing for Q1 2015, filed 14 May 2015.